The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Nanodrug delivery in reversing multidrug resistance in cancer cells
Open accessAbstract
Different mechanisms in cancer cells become resistant to one or more chemotherapeutics is known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential factors for MDR includes enhanced drug detoxification, decreased drug uptake, increased intracellular nucleophiles levels, enhanced repair of drug induced DNA damage, overexpression of drug transporter such as P-glycoprotein(P-gp), multidrug resistance-associated proteins (MRP1, MRP2), and breast cancer resistance protein (BCRP). Currently nanoassemblies such as polymeric/solid lipid/inorganic/metal nanoparticles, quantum dots, dendrimers, liposomes, micelles has emerged as an innovative, effective, and promising platforms for treatment of drug resistant cancer cells. Nanocarriers have potential to improve drug therapeutic index, ability for multifunctionality, divert ABC-transporter mediated drug efflux mechanism and selective targeting to tumor cells, cancer stem cells, tumor initiating cells, or cancer microenvironment. Selective nanocarrier targeting to tumor overcomes dose-limiting side effects, lack of selectivity, tissue toxicity, limited drug access to tumor tissues, high drug doses, and emergence of multiple drug resistance with conventional or combination chemotherapy. Current review highlights various nanodrug delivery systems to overcome mechanism of MDR by neutralizing, evading, or exploiting the drug efflux pumps and those independent of drug efflux pump mechanism by silencing Bcl-2 and HIF1α gene expressions by siRNA and miRNA, modulating ceramide levels and targeting NF-κB. "Theragnostics" combining a cytotoxic agent, targeting moiety, chemosensitizing agent, and diagnostic imaging aid are highlighted as effective and innovative systems for tumor localization and overcoming MDR. Physical approaches such as combination of drug with thermal/ultrasound/photodynamic therapies to overcome MDR are focused. The review focuses on newer drug delivery systems developed to overcome MDR in cancer cell.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Anand, P., Nair, H. B., Sung, B., Kunnumakkara, A. B., Yadav, V. R., Tekmal, R. R., & Aggarwal, B. B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.003 · Cited by 574
RetractedHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery
Kumar, C. S. S. R., & Mohammad, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.008 · Cited by 1,666
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Theranostics: Combining Imaging and Therapy
Kelkar, S. S., & Reineke, T. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200151q · Cited by 1,385
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Advances in polymeric micelles for drug delivery and tumor targeting
Kedar, U., Phutane, P., Shidhaye, S., & Kadam, V. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.05.005 · Cited by 791
Ceramide in apoptosis: an overview and current perspectives
Pettus, B. J., Chalfant, C. E., & Hannun, Y. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00331-1 · Cited by 788
Mesoporous silica nanoparticles in medicine—Recent advances
Mamaeva, V., Sahlgren, C., & Lindén, M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.018 · Cited by 707
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Fukumura, D., & Jain, R. K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.003 · Cited by 691
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Thomas, C. R., Ferris, D. P., Lee, J.-H., Choi, E., Cho, M. H., Kim, E. S., Stoddart, J. F., Shin, J.-S., Cheon, J., & Zink, J. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1022267 · Cited by 615
Ceramide: an intracellular signal for apoptosis
Hannun, Y. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88961-6 · Cited by 595
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 574
Polymeric micelles drug delivery system in oncology
Gong, J., Chen, M., Zheng, Y., Wang, S., & Wang, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.012 · Cited by 570
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
Indran, I. R., Tufo, G., Pervaiz, S., & Brenner, C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.03.010 · Cited by 526
Ganta, S., & Amiji, M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800240j · Cited by 490
Antony, A. C. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.002441 · Cited by 470
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
Thakor, A. S., Jokerst, J., Zavaleta, C., Massoud, T. F., & Gambhir, S. S. (2011) · Nano Letters · doi:10.1021/nl202559p · Cited by 468
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Min, K. H., Park, K., Kim, Y.-S., Bae, S. M., Lee, S., Jo, H. G., Park, R.-W., Kim, I.-S., Jeong, S. Y., Kim, K., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.013 · Cited by 460
The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?
Sharom, F. J. (1997) · Journal of Membrane Biology · doi:10.1007/s002329900305 · Cited by 458
Wei, Z., Hao, J., Yuan, S., Li, Y., Juan, W., Sha, X., & Fang, X. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.030 · Cited by 427
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Theranostic applications of nanoparticles in cancer
Ahmed, N., Fessi, H., & Elaissari, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.010 · Cited by 409
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Barnes, P. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00159-8 · Cited by 395
He, Q., Gao, Y., Zhang, L., Zhang, Z., Gao, F., Ji, X., Li, Y., & Shi, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.066 · Cited by 392
Gold nanoparticles: Emerging paradigm for targeted drug delivery system
Kumar, A., Zhang, X., & Liang, X.-J. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.10.002 · Cited by 371
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
Fox, E., & Bates, S. E. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.447 · Cited by 350
Kim, K., Kim, J. H., Park, H., Kim, Y.-S., Park, K., Nam, H., Lee, S., Park, J. H., Park, R.-W., & Kim, I.-S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.004 · Cited by 347
Maeng, J. H., Lee, D.-H., Jung, K. H., Bae, Y.-H., Park, I.-S., Jeong, S., Jeon, Y.-S., Shim, C.-K., Kim, W., Kim, J., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.068 · Cited by 333
Microenvironment-induced cancer metastasis
Rofstad, E. K. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138259 · Cited by 329
Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound
Gao, Z.-G., Fain, H. D., & Rapoport, N. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.021 · Cited by 328
Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity
Chanda, N., Kattumuri, V., Shukla, R., Zambre, A., Katti, K., Upendran, A., Kulkarni, R. R., Kan, P., Fent, G. M., Casteel, S. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002143107 · Cited by 321
Patil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current Progress
Dong, X., & Mumper, R. J. (2010) · Nanomedicine · doi:10.2217/nnm.10.35 · Cited by 317
Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., Wei, T., Cao, W., Zou, G., & Liang, X.-J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.058 · Cited by 315
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
Savla, R., Taratula, O., Garbuzenko, O., & Minko, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.015 · Cited by 314
Chen, Y., Yin, Q., Ji, X., Zhang, S., Chen, H., Zheng, Y., Sun, Y., Qu, H., Wang, Z., Li, Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.059 · Cited by 308
Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules
Vigderman, L., & Zubarev, E. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.05.004 · Cited by 305
Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304
Cho, H.-J., Yoon, H. Y., Koo, H., Ko, S.-H., Shim, J.-S., Lee, J.-H., Kim, K., Chan Kwon, I., & Kim, D.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.028 · Cited by 304
Nanotechnology applied to overcome tumor drug resistance
Gao, Z., Zhang, L., & Sun, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.051 · Cited by 303
Targeting cancer cells with biotin–dendrimer conjugates
Yang, W., Cheng, Y., Xu, T., Wang, X., & Wen, L.-P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.021 · Cited by 290
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
Kievit, F. M., Wang, F. Y., Fang, C., Mok, H., Wang, K., Silber, J. R., Ellenbogen, R. G., & Zhang, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.024 · Cited by 289
Hyperthermia – description of a method and a review of clinical applications
Chicheł, A., Skowronek, J., Kubaszewska, M., & Kanikowski, M. (2007) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/s1507-1367(10)60065-x · Cited by 284
Intracellular pH and the control of multidrug resistance.
Simon, S., Roy, D., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1128 · Cited by 276
Banerjee, R., Tyagi, P., Li, S., & Huang, L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20452 · Cited by 274
MacDiarmid, J. A., Amaro-Mugridge, N. B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., Brahmbhatt, V. N., Phillips, L., Pattison, S. T., Petti, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1547 · Cited by 272
Weber, C. E., & Kuo, P. C. (2012) · Surgical Oncology · doi:10.1016/j.suronc.2011.09.001 · Cited by 271
Cho, H.-J., Yoon, I.-S., Yoon, H. Y., Koo, H., Jin, Y.-J., Ko, S.-H., Shim, J.-S., Kim, K., Kwon, I. C., & Kim, D.-D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.064 · Cited by 267
Contributions of Cell Metabolism and H+ Diffusion to the Acidic pH of Tumors
Schornack, P. A., & Gillies, R. J. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80005-2 · Cited by 261
Quantum Dots for Cancer Diagnosis and Therapy: Biological and Clinical Perspectives
Zhang, H., Yee, D., & Wang, C. (2008) · Nanomedicine · doi:10.2217/17435889.3.1.83 · Cited by 260
Wu, C., Calcagno, A. M., & Ambudkar, S. V. (2008) · Current Molecular Pharmacology · doi:10.2174/1874-470210801020093 · Cited by 259
Liu, X., & Sun, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.069 · Cited by 253
Pan, L., Liu, J., He, Q., Wang, L., & Shi, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.040 · Cited by 252
The role of the myofibroblast in tumor stroma remodeling
Otranto, M., Sarrazy, V., Bonté, F., Hinz, B., Gabbiani, G., & Desmouliere, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20377 · Cited by 250
Update on taxane development: new analogs and new formulations
Tkaczuk, K., & Yared, J. (2012) · Drug Design, Development and Therapy · doi:10.2147/dddt.s28997 · Cited by 247
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery
Patil, Y. B., Toti, U. S., Khdair, A., Ma, L., & Panyam, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.056 · Cited by 242
Li, X., Chen, Y., Wang, M., Ma, Y., Xia, W., & Gu, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.072 · Cited by 239
Multifunctional superparamagnetic iron oxide nanoparticles: Promising tools in cancer theranostics
Santhosh, P. B., & Ulrih, N. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.032 · Cited by 236
Boddapati, S. V., D’Souza, G. G. M., Erdogan, S., Torchilin, V. P., & Weissig, V. (2008) · Nano Letters · doi:10.1021/nl801908y · Cited by 234
Siegal, T., Horowitz, A., & Gabizon, A. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.6.1029 · Cited by 232
The tumor microenvironment: a critical determinant of neoplastic evolution
van Kempen, L. C. L. T., Ruiter, D. J., van Muijen, G. N. P., & Coussens, L. M. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00346 · Cited by 231
Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., & Minko, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060240p · Cited by 226
Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles
Wang, H., Zheng, L., Peng, C., Guo, R., Shen, M., Shi, X., & Zhang, G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.001 · Cited by 226
The P-glycoprotein multidrug transporter
Fardel, O., Lecureur, V., & Guillouzo, A. (1996) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00081-x · Cited by 223
Chen, Y., Bathula, S. R., Li, J., & Huang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125906 · Cited by 216
Wu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 216
Schleich, N., Sibret, P., Danhier, P., Ucakar, B., Laurent, S., Muller, R. N., Jérôme, C., Gallez, B., Préat, V., & Danhier, F. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.042 · Cited by 215
Marin, A., Sun, H., Husseini, G. A., Pitt, W. G., Christensen, D. A., & Rapoport, N. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00262-6 · Cited by 213
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Wong, H. L., Bendayan, R., Rauth, A. M., & Wu, X. Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.007 · Cited by 207
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)
Nieth, C., Priebsch, A., Stege, A., & Lage, H. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00523-4 · Cited by 200
NF-κB modulation and ionizing radiation: mechanisms and future directions for cancer treatment
Magné, N., Toillon, R.-A., Bottero, V., Didelot, C., Houtte, P. V., Gérard, J.-P., & Peyron, J.-F. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.022 · Cited by 189
The packaging of siRNA within the mesoporous structure of silica nanoparticles
Li, X., Xie, Q. R., Zhang, J., Xia, W., & Gu, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.068 · Cited by 187
Gary-Bobo, M., Hocine, O., Brevet, D., Maynadier, M., Raehm, L., Richeter, S., Charasson, V., Loock, B., Morère, A., Maillard, P., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.11.045 · Cited by 186
NFκB: a promising target for natural products in cancer chemoprevention
Luqman, S., & Pezzuto, J. M. (2010) · Phytotherapy Research · doi:10.1002/ptr.3171 · Cited by 184
Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison
Kesharwani, P., Tekade, R. K., Gajbhiye, V., Jain, K., & Jain, N. K. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.10.010 · Cited by 184
Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Rosa Gasco, M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00562-7 · Cited by 180
Zhang, W., Shi, Y., Chen, Y., Yu, S., Hao, J., Luo, J., Sha, X., & Fang, X. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.04.017 · Cited by 180
Ma, P., Dong, X., Swadley, C. L., Gupte, A., Leggas, M., Ledebur, H. C., & Mumper, R. J. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1021 · Cited by 174
Nuclear factor-κB as a therapeutic target in critical care medicine
Zingarelli, B., Sheehan, M., & Wong, H. R. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301001-00015 · Cited by 174
Shen, J., He, Q., Gao, Y., Shi, J., & Li, Y. (2011) · Nanoscale · doi:10.1039/c1nr10580a · Cited by 172
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance
Gu, Y.-J., Cheng, J., Man, C. W.-Y., Wong, W.-T., & Cheng, S. H. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.005 · Cited by 171
Wang, F., Zhang, D., Zhang, Q., Chen, Y., Zheng, D., Hao, L., Duan, C., Jia, L., Liu, G., & Liu, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.041 · Cited by 170
Sahay, G., Kim, J. O., Kabanov, A. V., & Bronich, T. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.101 · Cited by 170
Mesoporous silica nanoparticles: A multifunctional nano therapeutic system
Mai, W. X., & Meng, H. (2012) · Integrative Biology · doi:10.1039/c2ib20137b · Cited by 164
Susa, M., Iyer, A. K., Ryu, K., Choy, E., Hornicek, F. J., Mankin, H. J., Milane, L. S., Amiji, M. M., & Duan, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010764 · Cited by 162
Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model
Bernardi, A., Braganhol, E., Jäger, E., Figueiró, F., Edelweiss, M. I., Pohlmann, A. R., Guterres, S. S., & Battastini, A. M. O. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.018 · Cited by 161
Combined cancer therapy by micellar-encapsulated drug and ultrasound
Rapoport, N. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.048 · Cited by 159
Robey, R. W., Shukla, S., Finley, E. M., Oldham, R. K., Barnett, D., Ambudkar, S. V., Fojo, T., & Bates, S. E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.12.001 · Cited by 158
Kim, E., Jung, Y., Choi, H., Yang, J., Suh, J., Huh, Y., Kim, K., & Haam, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.030 · Cited by 157
Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy
Kang, K. W., Chun, M., Kim, O., Subedi, R. K., Ahn, S., Yoon, J., & Choi, H. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.12.006 · Cited by 156
Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier
Teow, H. M., Zhou, Z., Najlah, M., Yusof, S. R., Abbott, N. J., & D’Emanuele, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.024 · Cited by 155
Fan, L., Li, F., Zhang, H., Wang, Y., Cheng, C., Li, X., Gu, C., Yang, Q., Wu, H., & Zhang, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.066 · Cited by 155
Nishiyama, N., Nakagishi, Y., Morimoto, Y., Lai, P., Miyazaki, K., Urano, K., Horie, S., Kumagai, M., Fukushima, S., Cheng, Y., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.010 · Cited by 154
Zhang, T., Chen, J., Zhang, Y., Shen, Q., & Pan, W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.005 · Cited by 152
van Vlerken, L. E., Duan, Z., Little, S. R., Seiden, M. V., & Amiji, M. M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800030k · Cited by 152
Lipid- and Polymer-Based Nanostructures for Cancer Theranostics
Luk, B. T., Fang, R. H., & Zhang, L. (2012) · Theranostics · doi:10.7150/thno.4381 · Cited by 148
Na, J. H., Koo, H., Lee, S., Min, K. H., Park, K., Yoo, H., Lee, S., Park, J. H., Kwon, I. C., Jeong, S. Y., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.076 · Cited by 145
Shen, J., Yin, Q., Chen, L., Zhang, Z., & Li, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.007 · Cited by 143
Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
Rapisarda, A., & Melillo, G. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.03.002 · Cited by 142
Gold Nanoparticles: Promising Nanomaterials for the Diagnosis of Cancer and HIV/AIDS
Kumar, A., Boruah, B. M., & Liang, X. (2011) · Journal of Nanomaterials · doi:10.1155/2011/202187 · Cited by 139
Quantum dots as versatile probes in medical sciences: Synthesis, modification and properties
Geszke-Moritz, M., & Moritz, M. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.01.003 · Cited by 136
Mei, L., Zhang, Y., Zheng, Y., Tian, G., Song, C. X., Yang, D., Chen, H., Sun, H., Tian, Y., Liu, K., et al. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9431-6 · Cited by 135
The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies
Schwartz, S. A., Hernandez, A., & Mark Evers, B. (1999) · Surgical Oncology · doi:10.1016/s0960-7404(00)00012-8 · Cited by 132
Zhang, X.-Q., Xu, X., Lam, R. T.-T., Giljohann, D. A., Ho, D., & Mirkin, C. A. (2011) · ACS Nano · doi:10.1021/nn201446c · Cited by 132
Khdair, A. A., Handa, H., Mao, G., & Panyam, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.017 · Cited by 129
Considerations in the design and development of transport inhibitors as adjuncts to drug therapy
Dantzig, A. H., de Alwis, D. P., & Burgess, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00175-8 · Cited by 129
Nombona, N., Maduray, K., Antunes, E. M., Karsten, A., & Nyokong, T. (2011) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2011.11.007 · Cited by 128
Milane, L. S., Ganesh, S., Shah, S., Duan, Z., & Amiji, M. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.032 · Cited by 128
Chanda, N., Shukla, R., Katti, K. V., & Kannan, R. (2009) · Nano Letters · doi:10.1021/nl8037147 · Cited by 127
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux
Chavanpatil, M. D., Patil, Y. B., & Panyam, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.045 · Cited by 124
Devalapally, H., Duan, Z., Seiden, M. V., & Amiji, M. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4973 · Cited by 121
Surfactant–Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug Efflux
Chavanpatil, M. D., Khdair, A., Gérard, B., Bachmeier, C. J., Miller, D. W., Shekhar, M. P. V., & Panyam, J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070024d · Cited by 117
Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives
Couvreur, P., & Vauthier, C. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90058-l · Cited by 115
In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma
de Mendoza, A. E., Véronique Préat, A., Mollinedo, F., & Blanco‐Prieto, M. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.030 · Cited by 112
Folate–PEG–superparamagnetic iron oxide nanoparticles for lung cancer imaging
Yoo, M.-K., Park, I., Lim, H.-T., Lee, S. J., Jiang, H., Kim, Y.-K., Choi, Y., Cho, M., & Cho, C. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.04.029 · Cited by 111
Majd, M. H., Asgari, D., Barar, J., Valizadeh, H., Kafil, V., Abadpour, A., Moumivand, E., Mojarrad, J. S., Rashidi, M., Coukos, G., et al. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.01.051 · Cited by 111
Devalapally, H., Duan, Z., Seiden, M. V., & Amiji, M. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22886 · Cited by 110
ERα signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer
Vekariya, K. K., Kaur, J., & Tikoo, K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.12.003 · Cited by 108
Conte, C., Ungaro, F., Maglio, G., Tirino, P., Siracusano, G., Sciortino, M. T., Leone, N., Palma, G., Barbieri, A., Arra, C., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.026 · Cited by 106
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles
Venishetty, V. K., Komuravelli, R., Kuncha, M., Sistla, R., & Diwan, P. V. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.003 · Cited by 104
Fang, C., Kievit, F. M., Omid Veiseh, A., Stephen, Z. R., Wang, T., Lee, D., Ellenbogen, R. G., & Zhang, M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.028 · Cited by 103
Das, M., & Sahoo, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032920 · Cited by 103
Yang, X., Koh, C. G., Liu, S., Pan, X., Santhanam, R., Yu, B., Peng, Y., Pang, J., Golan, S., Talmon, Y., et al. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800149s · Cited by 98
Beh, C. W., Seow, W. Y., Wang, Y., Zhang, Y., Ong, Z. Y., Ee, P. L. R., & Yang, Y. Y. (2008) · Biomacromolecules · doi:10.1021/bm801109g · Cited by 97
Chiu, S.-J., Liu, S., Perrotti, D., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.011 · Cited by 96
Cho, Y., Yoon, T., Jang, E., Hong, K. S., Lee, S. Y., Kim, O. R., Park, C.-S., Kim, Y.-J., Yi, G., & Chang, K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.08.004 · Cited by 96
The application of Fe3O4 nanoparticles in cancer research: A new strategy to inhibit drug resistance
Wang, X., Zhang, R., Wu, C., Dai, Y.-Y., Song, M., Gutmann, S., Gao, F., Lv, G., Li, J., Li, X., et al. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30901 · Cited by 95
Ling, Y., Wei, K., Zou, F., & Zhong, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.047 · Cited by 93
Koshkaryev, A., Piroyan, A., & Torchilin, V. P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.1.18871 · Cited by 92
Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant
Sharma, A. K., Zhang, L., Li, S., Kelly, D. L., Alakhov, V. Y., Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.031 · Cited by 92
Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences
Broxterman, H. J., Lankelma, J., & Hoekman, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00026-8 · Cited by 91
Emami, J., Rezazadeh, M., Varshosaz, J., Tabbakhian, M., & Aslani, A. (2012) · Journal of Nanomaterials · doi:10.1155/2012/358782 · Cited by 89
Pramanik, D., Campbell, N. R., Das, S., Gupta, S., Chenna, V., Bisht, S., Sysa‐Shah, P., Bedja, D., Karikari, C. A., Steenbergen, C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.543 · Cited by 89
Teng, I., Chang, Y. M., Wang, L., Lu, H.-Y., Wu, L.-C., Yang, C., Chiu, C., Yang, C.-H., Hsu, S., & Ho, J. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.001 · Cited by 88
Prasad, P., Shuhendler, A. J., Cai, P., Rauth, A. M., & Wu, X. Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.008 · Cited by 87
Liu, X., Ryland, L. K., Yang, J., Liao, A., Aliaga, C. A., Watters, R. J., Tan, S., Kaiser, J. M., Shanmugavelandy, S. S., Rogers, A., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271080 · Cited by 86
Oncological implications of hypoxia inducible factor-1α (HIF-1α) expression
O’Donnell, J. L., Joyce, M., Shannon, A. M., Harmey, J. H., Geraghty, J., & Bouchier‐Hayes, D. M. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.003 · Cited by 86
Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting
Li, M.-H., Choi, S. K., Thomas, T. P., Desai, A. M., Lee, K.-H., Kotlyar, A., Holl, M. M. B., & Baker, J. R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.11.027 · Cited by 85
Lee, D., Lockey, R. F., & Mohapatra, S. S. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.465 · Cited by 85
Luo, C., Zhu, Y., Jiang, T., Lu, X., Zhang, W., Jing, Q., Li, J., Pang, L., Chen, K., Qiu, F., et al. (2006) · Toxicology · doi:10.1016/j.tox.2006.10.020 · Cited by 80
Modulation of cell death in the tumor microenvironment
Wouters, B. G., Koritzinsky, M., Chiu, R. K., Theys, J., Buijsen, J., & Lambin, P. (2003) · Seminars in Radiation Oncology · doi:10.1053/srao.2003.50004 · Cited by 77
Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging
Kirui, D. K., Khalidov, I., Wang, Y., & Batt, C. A. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.009 · Cited by 76
Zhou, R., Mazurchuk, R., & Straubinger, R. M. (2002) · PubMed · Cited by 71
Cirstoiu-Hapca, A., Buchegger, F., Bossy-Nobs, L., Kosinski, M., Gurny, R., & Delié, F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.006 · Cited by 71
Recent progress in nanotechnology for cancer therapy
Tang, M.-F., Lei, L., Guo, S., et al. (2010) · 癌症:英文版 · doi:10.5732/cjc.010.10075 · Cited by 70
Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies
Jin, Y., Li, Jin, Y., Xie, Yao, Li, & Qiu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s27864 · Cited by 70
Ronaldson, P. T., Ashraf, T., & Bendayan, R. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.059410 · Cited by 69
Gokhale, P., Radhakrishnan, B., Husain, S., Abernethy, D., Sacher, R. A., Dritschilo, A., & Rahman, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.313 · Cited by 68
Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles
Liu, Q., Zhang, J., Xia, W., & Gu, H. (2012) · Nanoscale · doi:10.1039/c2nr30352c · Cited by 68
Self-assembled polypeptide-block-poly(vinylpyrrolidone) as prospective drug-delivery systems
Wang, L., Zeng, R., Li, C., & Qiao, R. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.07.032 · Cited by 68
Némati, F. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04559-0 · Cited by 67
Chen, Y., Zhang, W., Gu, J., Ren, Q., Fan, Z., Zhong, W., Fang, X., & Sha, X. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.015 · Cited by 66
Wang, J., Tao, X., Zhang, Y., Wei, D., & Ren, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.007 · Cited by 64
Tas, S. W., Vervoordeldonk, M. J., & Tak, P. P. (2009) · Current Gene Therapy · doi:10.2174/156652309788488569 · Cited by 62
Singh, A., Dilnawaz, F., & Sahoo, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026803 · Cited by 59
Gao, Y., Chen, L., Zhang, Z., Chen, Y., & Li, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.001 · Cited by 58
van Vlerken, L. E., Duan, Z., Little, S. R., Seiden, M. V., & Amiji, M. M. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9174-4 · Cited by 57
Sun (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2714 · Cited by 57
Xiao, J., Duan, X., Yin, Q., Miao, Z., Yu, H., Chen, C., Zhang, Z., Wang, J., & Li, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.084 · Cited by 54
Cytotoxic activity of G3 PAMAM-NH2 dendrimer-chlorambucil conjugate in human breast cancer cells
Bielawski, K., Bielawska, A., Muszyńska, A., Popławska, B., & Czarnomysy, R. (2011) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2011.08.002 · Cited by 51
Zhang, P., Ling, G., Sun, J., Zhang, T., Yuan, Y., Sun, Y., Wang, Z., & He, Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.022 · Cited by 51
Cathepsin B-sensitive nanoprobe for in vivo tumor diagnosis
Ryu, J. H., Kim, S. A., Koo, H., Yhee, J. Y., Lee, A., Na, J. H., Youn, I., Choi, K., Kwon, I. C., Kim, B., et al. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm13064a · Cited by 46
Chen, B., Li, K., Guohua, X., Cheng, J., Wang, J., FenGao, Xu, L., Feng, J., & Wang, X. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43752 · Cited by 44
Morad, S. A. F., Madigan, J. P., Levin, J. C., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.015 · Cited by 42
Howard, B., Gao, Z., Lee, S.-W., Seo, M.-H., & Rapoport, N. Y. (2006) · American Journal of Drug Delivery · doi:10.2165/00137696-200604020-00005 · Cited by 41
Jagani, H., Josyula, V. R., Palanimuthu, V. R., Hariharapura, R. C., & Gang, S. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.017 · Cited by 40
Han, M. Y., Diao, Y., Jiang, H., Ying, X., Chen, D., Liang, W., & Gao, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.09.009 · Cited by 39
Cambón, A., Rey‐Rico, A., Mistry, D., Brea, J. M., Loza, M. I., Attwood, D., Barbosa, S., Alvarez‐Lorenzo, C., Concheiro, Á., Taboada, P., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.056 · Cited by 38
Wu, F., Shao, Z.-Y., Zhai, B.-J., Zhao, C., & Shen, D.-M. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2010.10.009 · Cited by 38
Chen, B. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s7287 · Cited by 36
Lee, H., Kim, S., Choi, B., Park, M., Lee, J., Jeong, S., Choi, E. K., Lim, B., Kim, C., & Park, H. J. (2011) · International Journal of Hyperthermia · doi:10.3109/02656736.2011.608217 · Cited by 34
Chen, B. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s5093 · Cited by 33
Utilisation of Nanoparticle Technology in Cancer Chemoresistance
Ayers, D., & Nasti, A. (2012) · Journal of Drug Delivery · doi:10.1155/2012/265691 · Cited by 32
Hun, X., Zhang, Z., & Tiao, L. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.07.038 · Cited by 29
Zhang, G., Shi, L., Selke, M., & Wang, X. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-418 · Cited by 29
Inactivation of harmful tumour-associated proteolysis by nanoparticulate system
Kos, J., Obermajer, N., Doljak, B., Kocbek, P., & Kristl, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.037 · Cited by 28
Wan, C. P. L., Jackson, J. K., Pirmoradi, F. N., Chiao, M., & Burt, H. M. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.01.023 · Cited by 28
Paszko, E., Vaz, G. M. F., Ehrhardt, C., et al. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.018 · Cited by 24
Therapeutic Potential of RNA Interference in Drug-Resistant Cancers
Lage, H. (2009) · Future Oncology · doi:10.2217/14796694.5.2.169 · Cited by 22
Overcoming MDR by Ultrasound-Induced Hyperthermia and P-Glycoprotein Modulation
Yang, L., Lillehei, K. O., Cobb, W. N., Christians, U., & Ng, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5938 · Cited by 21
Al‐bataineh, M. M., van der Merwe, D., Schultz, B. D., & Gehring, R. (2010) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.731 · Cited by 19
Zhao, P., Wang, H., Gao, H., Li, C., & Zhang, Y. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000218 · Cited by 17
Kuo, W., Ku, Y., Sei, H., Cheng, F., & Yeh, C. (2009) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.200900136 · Cited by 16
Bcl-2 gene silence enhances the sensitivity toward 5-Fluorouracil in gastric adenocarcinoma cells
Yu, D.-F., Wu, F., Liu, Y., Liu, H., & Xia, Q. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.03.007 · Cited by 14
DRUG RESISTANCE PATHWAYS AS TARGETS
Tomida, A., & Tsuruo, T. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50006-1 · Cited by 11
Javid, A., Ahmadian, S., Saboury, A. A., & Rezaei‐Zarchi, S. (2011) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1328647 · Cited by 9
Ségui, B., Cuvillier, O., Malagarie‐Cazenave, S., Lévêque, S., Gouazé‐Andersson, V., Andrieu‐Abadie, N., & Levade, T. (2002) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-9272-7_8 · Cited by 4
Cited by
Mesoporous silica nanoparticles in target drug delivery system: A review
Bharti, C., Gulati, N., Nagaich, U., & Pal, A. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.160844 · Cited by 817
Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
Bayón-Cordero, L., Alkorta, I., & Arana, L. (2019) · Nanomaterials · doi:10.3390/nano9030474 · Cited by 344
Drug resistance in cancer: mechanisms and tackling strategies
Haider, T., Pandey, V., Banjare, N., Gupta, P. N., & Soni, V. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00138-7 · Cited by 282
Metadata
- Authors
- Yergeri, M., Kapse-Mistry, S., Srivastava, R., & Govender, T.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2014-07-10
- Volume
- 5
- Pages
- 159-159
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2094820979
- Cited by
- 255
- References
- 201
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.